Specialty
Monthly Archives: October 2023
October 19, 2023 3 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]
Abstract Objective Infants of mothers with adult congenital heart disease (ACHD) are at increased risk for adverse pregnancy and neonatal outcomes. We aim to identify mediators in the relationship between ACHD and pregnancy and infant outcomes. Study design Case-control study using linked maternal and infant hospital records. Structural equation modeling was performed to assess for […]
The American Red Cross continues to experience a national blood and platelet shortage and is asking the public to donate blood as soon as possible. Red Cross spokesperson Jen Warren says donors of all blood types are urgently needed, especially type O blood donors and those giving platelets. The Red Cross experienced a significant blood and platelet […]
Shannan N. Rich, PhD1,2; Amy Beeson, MD1,2; Leah Seifu, MD1,3; Kara Mitchell, PhD4; Danielle Wroblewski, MS4; Stefan Juretschko, PhD5; Marina Keller, MD6; Rachel Gnanaprakasam, MBBS6; Mariam Agladze, MD7; Rich Kodama, DO8; Tania Kupferman, MD7; Julu Bhatnagar, PhD9; Roosecelis B. Martines, MD, PhD9; Sarah Reagan-Steiner, MD9; Sally Slavinski, DVM3; Matthew J. Kuehnert, MD10; Camille Bergeron-Parent, MD3; […]
Human skin organoids are susceptible to mpox virus infection and support infectious virus production. Treatment of infected skin organoids with the antiviral drug tecovirimat can inhibit infectious virus production and prevent host transcriptome rewiring. Thus, skin-organoid-based models are robust for studying mpox virus infection and testing therapeutics. This is a preview of subscription content, access […]
This is with a view of paving the way for developing new therapies and tools for detection and diagnosis of the disease. Walgreens says it intends to use its national presence, strong community relationships and data-driven clinical trials solutions to help identify and reach potential new study participants. “The aging population has led to a […]